Sponsors (10)
The bill could improve survival from anaphylaxis and increase transparency by enabling officer access to epinephrine, public education, and reporting — but its lack of dedicated funding, potential administrative burdens, privacy and liability risks, and tight timelines mean those benefits may be uneven or fail to materialize without further implementation safeguards.
People with severe allergic reactions and the general public: law enforcement are encouraged/authorized and could obtain and administer emergency epinephrine on-scene, enabling faster life‑saving treatment.
Communities, local/state governments, and policymakers: creation of a reporting requirement for officer epinephrine use provides publicly available data to identify training or access gaps and inform policy or funding decisions.
Parents, children, and the general public: a federally coordinated public education campaign will increase recognition of anaphylaxis symptoms and standardize messaging across jurisdictions, improving timely care.
Local law enforcement agencies and communities: the bill contains no dedicated funding, implementation details, or enforceable obligations, so agencies may not receive supplies, training, or other support and intended benefits may not materialize.
Law enforcement agencies and federal employees: the reporting mandate creates additional administrative burden and costs for data collection and submission without providing funding.
Patients and community members: public release of incident-level epinephrine administration data could risk privacy harms if not properly de‑identified.
Based on analysis of 4 sections of legislative text.
Creates a statutory law enforcement epinephrine grant program (no funding specified), requires annual federal reporting on officer epinephrine use, and orders an HHS/DOJ public awareness campaign within 180 days.
Introduced June 17, 2025 by Laura Gillen · Last progress June 17, 2025
Creates a federal grant program framework to improve law enforcement access to emergency epinephrine (implementation details and funding are not specified), requires the Department of Justice’s Bureau of Justice Statistics to publish annual data on how often law enforcement administers epinephrine products, and directs the Attorney General and HHS to run a public awareness campaign about anaphylaxis and first responder use of epinephrine within 180 days of enactment.